(Press-News.org) HOUSTON -- Contrary to long-held beliefs, Type I collagen produced by cancer-associated fibroblasts may not promote cancer development but instead plays a protective role in controlling pancreatic cancer progression, reports a new study from researchers at The University of Texas MD Anderson Cancer Center. This new understanding supports novel therapeutic approaches that bolster collagen rather than suppress it.
The study finds that collagen works in the tumor microenvironment to stop the production of immune signals, called chemokines, that lead to suppression of the anti-tumor immune response. When collagen is lost, chemokine levels increase, and the cancer is allowed to grow more rapidly. The research was published today in Cancer Cell.
"Collagen has been the most highly studied component of the tumor microenvironment for decades, but its precise role has remained unclear," said senior author Raghu Kalluri, M.D., Ph.D., chair of Cancer Biology. "Now, we understand that it is part of a cancer defensive strategy of the body. If we can better understand that strategy, even if it may be suboptimal, we can work to shore up our body's natural defenses to have therapeutic impact."
Collagen, the most abundant protein in the human body, is produced by a class of cells called fibroblasts and is found mostly in bones, tendons and skin. The protein also tends to accumulate in and around tumors during cancer development and growth, leading researchers to hypothesize that it helps promote tumor growth, metastasis or drug resistance, Kalluri explained.
To investigate these possibilities and clarify the role of collagen, the research team created a mouse model in which collagen is not produced by cancer-associated fibroblasts during pancreatic cancer development. After genetically deleting collagen from these cells, called myofibroblasts, more than 50% of the total collagen was absent in the tumor microenvironment.
With collagen reduced, pancreatic cancer growth accelerated, and the overall survival of the mice significantly decreased, suggesting that collagen plays an important role in blocking cancer progression.
The researchers looked further to understand how collagen was impacting tumor development. In tumors with reduced collagen, the cancer cells produced higher levels of chemokines known to attract myeloid-derived suppressor cells (MDSCs), a type of immune cell that dampens anti-tumor immune response.
Indeed, the researchers found that collagen-deficient tumors had more MDSCs present and fewer immune cells, such as T cells and B cells, that could mount an effective anti-tumor response. Interestingly, blocking chemokine signaling activity with targeted therapies reversed the immune profile in these tumors and slowed tumor progression, bringing it back to a level similar to that of controls.
"This was somewhat surprising because we think of pancreatic cancer as a cancer with poor immune surveillance - with an immunosuppressive tumor microenvironment," Kalluri said. "However, this study shows that the immune system actually is controlling pancreatic tumor growth to some extent, and we see an even more detrimental immune suppressive tumor microenvironment when collagen is lost."
Noting that pancreatic cancer is one of the most aggressive tumor types with poor outcomes overall, Kalluri acknowledged that collagen by itself may not be a particularly effective defense mechanism, but it shows that our bodies are doing what they can to control cancer development.
He likens the body's response to a car with faulty brakes. The car cannot stop as efficiently as it might with good brakes, but it is better than a car with no brakes at all.
The challenge now, Kalluri explained, is to identify a therapeutic strategy to fix those brakes, by increasing collagen levels or boosting collagen's downstream effects to further strengthen the anti-tumor response. Exploring these strategies will be the focus of future work by Kalluri's team.
INFORMATION:
This research was supported by the Cancer Prevention & Research Institute of Texas (RP150231) and the National Cancer Institute (PO1CA95616). Collaborating authors on the MD Anderson study include: Yang Chen, Ph.D., Jiha Kim, Ph.D., Sujuan Yang, Hikaru Sugimoto, M.D., Ph.D., and Valerie S. LeBleu, Ph.D., all of Cancer Biology; Huamin Wang, M.D., Ph.D., of Translational Molecular Pathology; and Chang-Jiun Wu, Ph.D., of Genomic Medicine. The authors declare no conflicts of interest.
Digital solutions including remote monitoring can help chronic pain sufferers manage their pain and reduce the probability of misuse of prescription opioids.
For chronic pain sufferers an app may be just the tool they need to manage their pain. In a UHN-led study that used the app "Manage My Pain" enrolled patients saw clinically significant reductions in key areas that drive increased medical needs, potential abuse of prescription opioids and of course, pain.
Toronto (March 4, 2021) - For the first time, an app has been shown to reduce key symptoms of chronic pain. A UHN-led study evaluated the impact of Manage My Pain (MMP), a digital health solution developed ...
The body's immune response plays a crucial role in the course of a SARS-CoV-2 infection. In addition to antibodies, the so-called T-killer cells, are also responsible for detecting viruses in the body and eliminating them. Scientists from the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Medical University of Vienna have now shown that SARS-CoV-2 can make itself unrecognizable to the immune response by T-killer cells through mutations. The findings of the research groups of Andreas Bergthaler, Judith Aberle and Johannes Huppa provide important clues for the further development of vaccines and were published in the journal Science ...
A recent study outlines a range of privacy concerns related to the programs that users interact with when using Amazon's voice-activated assistant, Alexa. Issues range from misleading privacy policies to the ability of third-parties to change the code of their programs after receiving Amazon approval.
"When people use Alexa to play games or seek information, they often think they're interacting only with Amazon," says Anupam Das, co-author of the paper and an assistant professor of computer science at North Carolina State University. "But a lot of the applications they are interacting with were created by third parties, and we've identified several flaws in the current vetting process that could allow those third parties to gain access to users' personal or private ...
Cervical cancer is a serious global health threat which kills more than 300,000 women every year. It's a disease that disproportionately affects women in low- and middle-income countries in equatorial Africa, Latin America and Southeast Asia, yet it is a preventable disease and decades of research have produced the tools needed to eliminate it.
Recognizing this urgent public health issue, the editorial team of Preventive Medicine, led by Editor-in-Chief Dr. Eduardo Franco, Director, Division of Cancer Epidemiology and Chair, Gerald Bronfman Department ...
Researchers in Japan have developed the first wearable devices to precisely monitor jaundice, a yellowing of the skin caused by elevated bilirubin levels in the blood that can cause severe medical conditions in newborns. Jaundice can be treated easily by irradiating the infant with blue light that breaks bilirubin down to be excreted through urine. The treatment itself, however, can disrupt bonding time, cause dehydration and increase the risks of allergic diseases. Neonatal jaundice is one of the leading causes of death and brain damage in infants in low- and middle-income countries.
To address the tricky balance ...
On Earth, plate tectonics is not only responsible for the rise of mountains and earthquakes. It is also an essential part of the cycle that brings material from the planet's interior to the surface and the atmosphere, and then transports it back beneath the Earth's crust. Tectonics thus has a vital influence on the conditions that ultimately make Earth habitable.
Until now, researchers have found no evidence of global tectonic activity on planets outside our solar system. A team of researchers led by Tobias Meier from the Center for Space and Habitability (CSH) at the University of Bern and with the participation of ETH Zurich, the University of Oxford and the National Center of Competence in Research NCCR PlanetS has now found evidence of the flow patterns inside ...
Female gannets travel further than male gannets to find fish for their chicks in some years but not others, new research shows.
Scientists tracked breeding gannets from Grassholm Island in Wales over 11 years with tiny GPS devices and by measuring isotopic signatures in their blood.
Male gannets flew an average of 220km to forage for their chicks, while females averaged 260km. Some birds travelled 1,000km on a single trip.
The scientists also found that the two sexes selected different habitats and foraged at different times of day, but some years ...
COLUMBUS, Ohio - Putting a price on producing carbon is the cheapest, most efficient policy change legislators can make to reduce emissions that cause climate change, new research suggests.
The case study, published recently in the journal Current Sustainable/Renewable Energy Reports, analyzed the costs and effects that a variety of policy changes would have on reducing carbon dioxide emissions from electricity generation in Texas and found that adding a price, based on the cost of climate change, to carbon was the most effective.
"If the goal is reducing carbon dioxide in the atmosphere, what we found is that putting a price on carbon and then letting suppliers and consumers make their ...
In order to show the clinical relevance of a difference between two treatment alternatives, in recent years, the manufacturer dossiers submitted in early benefit assessments of new drugs have increasingly contained responder analyses for patient-relevant outcomes. In such analyses, it is investigated whether the proportion of patients experiencing a noticeable change in the respective outcome differs between the two treatment groups in a study. This involves information on health-related quality of life or on individual symptoms such as pain or itching, which patients recorded with the help of scales in questionnaires.
But what difference makes a change relevant for the individual? That is, at what threshold can a response to an intervention be derived for ...
A deep sequencing study of 747 SARS-CoV-2 virus isolates has revealed mutant peptides derived from the virus that cannot effectively bind to critical proteins on the surface of infected cells and, in turn, hamper activation of CD8+ killer T cells that recognize and destroy these infected cells. These peptides, the authors say, represent one way the coronavirus subverts killer T cell responses and stymies immunity in the host. Their results may be of particular importance for SARS-CoV-2 subunit vaccines, such as the RNA vaccines currently in use, which induce responses against a limited number of viral ...
